Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06315829
Other study ID # IRB00429753
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date May 2024
Est. completion date May 2026

Study information

Verified date March 2024
Source Johns Hopkins University
Contact Glenn Rivera, MD
Phone 410-955-4259
Email griver14@jh.edu
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Infantile spasms are a type of seizure linked to developmental issues. Unfortunately, they are often misdiagnosed, causing delays in treatment. The purpose of this study is to develop a computer program that can reliably differentiate infantile spasms from similar, yet benign movements in videos. This computer program will learn from videos taken by parents of study participants. Quickly recognizing and treating infantile spasms is crucial for ensuring the best developmental outcomes.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 200
Est. completion date May 2026
Est. primary completion date May 2026
Accepts healthy volunteers No
Gender All
Age group N/A to 2 Years
Eligibility Inclusion Criteria: - Participant age less than 24 months - Participant evaluated in the Johns Hopkins Outpatient Center, Johns Hopkins Pediatric Emergency Department or Johns Hopkins Inpatient Units due to spells of abnormal movement or seizure - Participant evaluated by a pediatric neurologist during the outpatient or inpatient visit at Johns Hopkins Hospital - At least one video recording of the spell of abnormal movement produced by the parent/guardian available for provider review Exclusion Criteria: - Poor video recording quality - Entire patient is not in frame

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Spasm Vision
Machine learning software developed to analyze videos and accurately distinguish infantile spasms from visually similar movements.

Locations

Country Name City State
United States Johns Hopkins Hospital Baltimore Maryland

Sponsors (1)

Lead Sponsor Collaborator
Johns Hopkins University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Model Sensitivity (Recall) Proportion of true positives which the model classified correctly in the test dataset. 2 years
Primary Model Specificity Proportion of true negatives which the model classified correctly in the test dataset. 2 years
Primary Model Positive Predictive Value (Precision) Proportion of positive classifications which were correct in the test dataset. 2 years
Primary Model Negative Predictive Value Proportion of negative classifications which were correct in the test dataset. 2 years
See also
  Status Clinical Trial Phase
Withdrawn NCT02299115 - Prednisolone Versus Vigabatrin in the First-line Treatment of Infantile Spasms Phase 3
Completed NCT02885389 - Molecular Genetics in Infantile Spasms N/A
Completed NCT01006811 - Use of the Modified Atkins Diet in Infantile Spasms Phase 2/Phase 3
Completed NCT01828437 - Addition of Pyridoxine to Prednisolone in Infantile Spasms Phase 3
Recruiting NCT01858285 - Genetics of Epilepsy and Related Disorders
Completed NCT00552045 - Epilepsy Phenome/Genome Project
Completed NCT02220114 - Acceptability Study of a New Paediatric Form of Vigabatrin in Infants and Children With Infantile Spasms or Pharmacoresistant Partial Epilepsy N/A
Completed NCT02954887 - Phase 3 Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms: Open-label Extension Phase (GWPCARE7) Phase 3
Completed NCT01723787 - Genetic Studies in Patients and Families With Infantile Spasms
Completed NCT02092883 - Evaluation of Neuroinflammation in Children With Infantile Spasms Phase 4
Withdrawn NCT01413711 - An Open-Label, Single and Multiple Oral Dose Pharmacokinetic Study of Vigabatrin in Infants With Infantile Spasms Phase 4
Completed NCT00441896 - A Randomized, Controlled Trial of Ganaxolone in Patients With Infantile Spasms Phase 2
Terminated NCT00442104 - Open-label Extension to Protocol 1042-0500 Phase 2
Withdrawn NCT01549288 - Trial of the Modified Atkins Diet in Infantile Spasms Refractory to Hormonal Therapy Phase 2/Phase 3
Completed NCT01575639 - Prednisolone in Infantile Spasms- High Dose Versus Usual Dose Phase 3
Completed NCT01073579 - Sabril Patient Registry N/A
Completed NCT02953548 - Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms (GWPCARE7) Phase 3
Completed NCT00001325 - Metabolic Abnormalities in Children With Epilepsy N/A
Completed NCT00968136 - Short-term Ketogenic Diet as Compared With Conventional Long-term Trial in Refractory Infantile Spasms: A Randomized, Controlled Study N/A